Animalcare Group plc

ANCR

GB0032350695

Pharmaceuticals

Delayed London S.E. Other stock markets 11:24:19 2024-04-29 am EDT			5-day change	1st Jan Change
228.8 ^GBX	+5.44%		+5.44%	+34.59%

Apr. 15	Transcript : Animalcare Group plc, 2023 Earnings Call, Apr 15, 2024
Apr. 11	Animalcare to sell 33% stake in STEM Animal Health to Dechra	AN

Animalcare Group plc Provides Revenue Guidance for the Full Year 2023

September 26, 2023 at 02:00 am EDT

Animalcare Group plc provided revenue guidance for the full year 2023. The company anticipated an improvement in second half performance versus fiscal year 2022 and with it, a return to revenue growth for the full year 2023.

Latest news about Animalcare Group plc

Transcript : Animalcare Group plc, 2023 Earnings Call, Apr 15, 2024	Apr. 15
Animalcare to sell 33% stake in STEM Animal Health to Dechra	Apr. 11	AN
Dechra Pharmaceuticals Limited reached agreement in principle to acquire 33.34% stake in STEM Animal Health Inc. for $4.7 million.	Apr. 10	CI
FTSE 100 Closes Down 0.1% as ECB Rate-Cut Hopes Wane	Apr. 09	DJ
Animalcare ups dividend on 2023 results as chair announces retirement	Apr. 09	AN
Transcript : Animalcare Group plc, 2023 Earnings Call, Apr 09, 2024	Apr. 09
Earnings Flash (ANCR.L) ANIMALCARE GROUP Reports FY23 Revenue GBP74.4M	Apr. 09	MT
Earnings Flash (ANCR.L) ANIMALCARE GROUP Posts FY23 EPS GBX2.00	Apr. 09	MT
Animalcare Group plc Proposes Final Dividend for the Year Ended 31 December 2023, Payable on July 19, 2024	Apr. 09	CI
Animalcare Group plc Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 09	CI
AB Dynamics trades in line; Verditek sells solar arm	Feb. 28	AN
Animalcare Group to Sells Identicare in GBP25 Million Deal	Feb. 28	MT
AIM WINNERS & LOSERS: Image Scan falls on slower start to 2024	Feb. 28	AN
BG Bidco 21 Limited acquired unknown majority shares in Identicare Limited from Animalcare Group plc for £24.9 million.	Feb. 27	CI
Treatt revenue falls; Secure Trust profit picks up	Jan. 25	AN
EARNINGS: Andrews Sykes revenue up; Safestay optimistic	23-09-26	AN
Transcript : Animalcare Group plc, H1 2023 Earnings Call, Sep 26, 2023	23-09-26
Earnings Flash (ANCR.L) ANIMALCARE GROUP Posts H1 Revenue GBP36.7M	23-09-26	MT
Animalcare Group plc Reports Earnings Results for the Half Year Ended June 30, 2023	23-09-26	CI
Animalcare Group plc Provides Revenue Guidance for the Full Year 2023	23-09-26	CI
Animalcare Group plc Declares an Interim Dividend, Payable on November 17, 2023	23-09-26	CI
Kane Biotech Engages Research Capital to Conduct Strategic Review of STEM Animal Health	23-08-02	MT
Volex, Eleco, Fintel trading in line with forecast	23-07-27	AN
Animalcare Group plc Provides Earnings Guidance for the Six Months Ended 30 June 2023	23-07-27	CI
Kane Biotech Says Skout's Honor Pet Supply Signed coactiv+ Animal Health Licensing Pact; Up Nearly 9%	23-04-18	MT

Chart Animalcare Group plc

Duration

Period

More charts

Company Profile

Animalcare Group plc is a United Kingdom-based international veterinary sales and marketing company. The Company is focused on bringing products to market through its own development pipeline, partnerships and through acquisitions. The Company develops and commercializes prescription and over-the-counter pharmaceutical products that improve animal health and wellbeing. These are developed in-house, acquired from other companies or in-licensed from its partners. The Company manages an international supply chain, including specialist veterinary wholesalers and distributors. It partners with companies to commercialize products across Europe. The Company operates in three categories within the veterinary market: companion animals, equine and other, and production animals. Its product pipeline is Daxocox, which is a differentiated COX-2 inhibitor for the treatment of chronic pain in dogs. The Company operates in seven countries and exports to about 40 countries in Europe and worldwide.

Sector

Pharmaceuticals

Calendar

2024-06-19 - Final dividend

More about the company

Income Statement Evolution

More financial data

Ratings for Animalcare Group plc

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

2.17 GBP

Average target price

2.935 GBP

Spread / Average Target

+35.25%

Consensus

Annual profits - Rate of surprise

Company calendar

Sector Veterinary Drugs

	1st Jan change	Capi.
ANIMALCARE GROUP PLC	+34.59%	162M
ZOETIS INC.	-17.98%	72.39B
ELANCO ANIMAL HEALTH INCORPORATED	-7.55%	6.54B
BLUESTAR ADISSEO COMPANY	+15.88%	3.43B
VIMIAN GROUP AB	+1.18%	1.4B
JINYU BIO-TECHNOLOGY CO., LTD.	-17.27%	1.34B
VETOQUINOL SA	-3.81%	1.26B
CHINA ANIMAL HUSBANDRY INDUSTRY CO., LTD.	-28.16%	1.2B
WUHAN KEQIAN BIOLOGY CO.,LTD	-14.67%	1.12B
TIANJIN RINGPU BIO-TECHNOLOGY CO.,LTD.	-5.37%	990M

Veterinary Drugs